Abstract
Intestinal mucosa is the interface between the microbial content of the gut and the host’s milieu. The goal of this study was to modulate chicken intestinal microflora by in ovo stimulation with galactooligosaccharides (GOS) prebiotic and to demonstrate the molecular responses of the host. The animal trial was performed on meat-type chickens (Ross 308). GOS was delivered by in ovo injection performed into the air cell on day 12 of egg incubation. Analysis of microbial communities and mucosal gene expression was performed at slaughter (day 42 post-hatching). Chyme (for DNA isolation) and intestinal mucosa (for RNA isolation) from four distinct intestinal segments (duodenum, jejunum, ileum, and caecum) was sampled. The relative abundance of Bifidobacterium spp. and Lactobacillus spp. in DNA isolated from chyme samples was determined using qPCR. On the host side, the mRNA expression of 13 genes grouped into two panels was analysed with RT-qPCR. Panel (1) included genes related to intestinal innate immune responses (IL-1β, IL-10 and IL-12p40, AvBD1 and CATHL2). Panel (2) contained genes involved in intestinal barrier function (MUC6, CLDN1 and TJAP1) and nutrients sensing (FFAR2 and FFAR4, GLUT1, GLUT2 and GLUT5). GOS increased the relative abundance of Bifidobacterium in caecum (from 1.3% to 3.9%). Distinct effects of GOS on gene expression were manifested in jejunum and caecum. Cytokine genes (IL-1β, IL-10 and IL-12p40) were up-regulated in the jejunum and caecum of the GOS-treated group. Host defence peptides (AvBD1 and CATHL2) were up-regulated in the caecum of the GOS-treated group. Free fatty acid receptors (FFAR2 and FFAR4) were up-regulated in all three compartments of the intestine (except the duodenum). Glucose transporters were down-regulated in duodenum (GLUT2 and GLUT5) but up-regulated in the hindgut (GLUT1 and GLUT2). In conclusion, GOS delivered in ovo had a bifidogenic effect in adult chickens. It also modulated gene expression related to intestinal immune responses, gut barrier function, and nutrient sensing.
Highlights
Mucous tissue lines the gastrointestinal tract (GIT)
Panel (2) contained genes involved in intestinal barrier function and nutrient sensing, including mucous compound (MUC6), tight junctions (TJ) proteins (CLDN1 and TJAP1), free fatty acids (FFA) receptors (FFAR2 and FFAR4) and glucose transporters (GLUT1, GLUT2 and GLUT5)
In Bifidobacterium spp. we found significant interaction between the intestinal section and prebiotic supplementation (P < 0.05)
Summary
Mucous tissue lines the gastrointestinal tract (GIT). It is composed of a vast surface area that forms an interface between luminal microflora and internal body structures. Mucosa is in constant cross-talk with the microbiome and reacts directly to signals from the gut environment [1] The effects of such interaction on the host are immense: from intestinal health, improved digestion, metabolism regulation, and maturation of the immune system, to regulation of behaviour and body weight [2]. Some of them, including a low-fibre diet or use of antimicrobials or enteric infection agents, decrease the biodiversity and abundance of the beneficial microflora [3]. Others, such as prebiotics, probiotics, synbiotics, or postbiotics, exert positive effects on the composition of the gut microflora [3]. Focus on the mucosa may help explain the mechanisms that follow microbiota modulation
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
